PIN53 - IS THE RECOMBINANT ZOSTER VACCINE ALSO COST-EFFECTIVE FOR THE GERMAN POPULATION ≥50 YEARS OF AGE?
Abstract
Authors
A. Anastassopoulou D. Van Oorschot B. Poulsen Nautrup L. Varghese A. von Krempelhuber M. Neine S. Lorenc D. Curran